Annual Total Liabilities
$27.60 M
+$6.40 M+30.16%
December 31, 2024
Summary
- As of March 12, 2025, EWTX annual total liabilities is $27.60 million, with the most recent change of +$6.40 million (+30.16%) on December 31, 2024.
- During the last 3 years, EWTX annual total liabilities has risen by +$16.75 million (+154.39%).
- EWTX annual total liabilities is now -83.23% below its all-time high of $164.56 million, reached on December 31, 2020.
Performance
EWTX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$27.60 M
+$5.20 M+23.19%
December 31, 2024
Summary
- As of March 12, 2025, EWTX quarterly total liabilities is $27.60 million, with the most recent change of +$5.20 million (+23.19%) on December 31, 2024.
- Over the past year, EWTX quarterly total liabilities has increased by +$5.20 million (+23.19%).
- EWTX quarterly total liabilities is now -83.23% below its all-time high of $164.56 million, reached on December 31, 2020.
Performance
EWTX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
EWTX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.2% | +23.2% |
| 3 y3 years | +154.4% | +31.8% |
| 5 y5 years | -33.3% | +31.8% |
EWTX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +154.4% | at high | +154.4% |
| 5 y | 5-year | -83.2% | +154.4% | -83.2% | +469.0% |
| alltime | all time | -83.2% | +154.4% | -83.2% | +469.0% |
Edgewise Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $27.60 M(+30.2%) | $27.60 M(+23.2%) |
| Sep 2024 | - | $22.41 M(+5.8%) |
| Jun 2024 | - | $21.17 M(+12.2%) |
| Mar 2024 | - | $18.86 M(-11.0%) |
| Dec 2023 | $21.20 M(+4.0%) | $21.20 M(+1.3%) |
| Sep 2023 | - | $20.94 M(+9.2%) |
| Jun 2023 | - | $19.17 M(+9.2%) |
| Mar 2023 | - | $17.56 M(-13.9%) |
| Dec 2022 | $20.39 M | $20.39 M(+29.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $15.75 M(+42.6%) |
| Jun 2022 | - | $11.04 M(-10.9%) |
| Mar 2022 | - | $12.39 M(+14.2%) |
| Dec 2021 | $10.85 M(-93.4%) | $10.85 M(+19.9%) |
| Sep 2021 | - | $9.05 M(+34.3%) |
| Jun 2021 | - | $6.74 M(+38.9%) |
| Mar 2021 | - | $4.85 M(-97.1%) |
| Dec 2020 | $164.56 M(+297.5%) | $164.56 M |
| Dec 2019 | $41.39 M | - |
FAQ
- What is Edgewise Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Edgewise Therapeutics?
- What is Edgewise Therapeutics annual total liabilities year-on-year change?
- What is Edgewise Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Edgewise Therapeutics?
- What is Edgewise Therapeutics quarterly total liabilities year-on-year change?
What is Edgewise Therapeutics annual total liabilities?
The current annual total liabilities of EWTX is $27.60 M
What is the all time high annual total liabilities for Edgewise Therapeutics?
Edgewise Therapeutics all-time high annual total liabilities is $164.56 M
What is Edgewise Therapeutics annual total liabilities year-on-year change?
Over the past year, EWTX annual total liabilities has changed by +$6.40 M (+30.16%)
What is Edgewise Therapeutics quarterly total liabilities?
The current quarterly total liabilities of EWTX is $27.60 M
What is the all time high quarterly total liabilities for Edgewise Therapeutics?
Edgewise Therapeutics all-time high quarterly total liabilities is $164.56 M
What is Edgewise Therapeutics quarterly total liabilities year-on-year change?
Over the past year, EWTX quarterly total liabilities has changed by +$5.20 M (+23.19%)